Sonoma Bio Raises $265m To Test T-regs In Autoimmune Diseases
First Indication Is RA, But IBD Is Another Opportunity
Sonoma Bio's T-reg therapies may offer a polypharmacy approach to treating rheumatoid arthritis and other autoimmune diseases • Source: Alamy 
